SMARCB1 and neoplasm: Mutations typically lead to loss of function, suggesting tumor suppressor roles of BAF complexes, in particular in childhood malignant rhabdoid tumors (loss of SMARCB1/SNF5) (29) as well as ovarian and endometrial carcinomas (ARIAD1A) (30, 31).